The BTB/POZ family of proteins has been implicated in multiple biological processes, including tumourigenesis, DNA damage responses and cell cycle progression and development. MIZ-1 (Myc-interacting zinc-finger protein 1) is known to activate transcription of CDKN1A.
Introduction
The BTB/POZ domain proteins were originally found in Drosophila melanogaster, bric-a-brac, tramtrack and broad complex transcription regulators (Koonin et al., 1992; Aravind and Koonin 1999) and in pox virus zincfinger proteins. The BTB/POZ domain proteins have an evolutionarily conserved protein-protein interaction domain at their N-termini, called the BTB/POZ domain (Bardwell and Treisman, 1994; Albagli et al., 1995) . These proteins have been identified in organisms ranging from human to yeast. About 40 of the 194 human BTB/ POZ domain, regulatory proteins are classified as POK family proteins. POK proteins are made up of an N-terminal POZ domain, which has an important role in forming homo-or hetero-dimers and interacting with other proteins, and a C-terminal Kru¨ppel-type (C 2 H 2 ) zinc-finger domain, which recognizes and binds to specific DNA sequences. These proteins have been implicated in many biological processes, and in particular, some of the POK proteins were shown to act as major regulators of apoptosis (Yamochi et al., 1999) , differentiation, development (Farkas et al., 1994; Barna et al., 2000) , transcription (Chang et al., 1996; Dong et al., 1996; Dhordain et al., 1997; Lin et al., 1998; Deltour et al., 1999; Huynh et al., 2000; Maeda et al., 2005; Jeon et al., 2008; Choi et al., 2008) and oncogenesis (Chen et al., 1993; Kerckaert et al., 1993; Maeda et al., 2005) .
Promyelocytic leukaemia zinc-finger null mice display severe defects in limb development and germ stem cell maintenance (Barna et al., 2000; Costoya et al., 2004) . T-helper-inducing POZ/Kru¨ppel-like factor, also known as cKrox, has recently been reported as a master regulator of T-cell lineage commitment (He et al., 2010) . B-cell lymphoma 6 (Bcl-6), promyelocytic leukaemia zinc finger and hypermethylated in cancer-1 have been implicated in non-Hodgkin's lymphoma, acute promyelocytic leukaemia and spontaneous malignant tumours, respectively (Chen et al., 1993; Kerckaert et al, 1993; Issa et al., 1997) . Along with others, we recently found that FBI-1 stimulates cell proliferation and is a potent proto-oncoprotein (Maeda et al., 2005; Jeon et al., 2008; Choi et al., 2009) . We also showed that FBI-1 increases FASN gene expression and thereby provides phospholipid cell membrane components to meet the lipid needs of rapidly proliferating cancer cells . Along with others, we have shown that POK proteins, including FBI-1 , ZBTB2 , ZBTB4 (Weber et al., 2008) , ZBTB5 (Koh et al., 2009) and BCL6 (Peukert et al., 1997) have major influences on the regulation of the p53 pathway.
Among the genes of p53 pathway, the cyclindependent kinase inhibitor p21 is a downstream regulator of the ARF-HDM2-p53-p21 pathway and is a major regulator of cell cycle arrest in mammalian cells (el-Deiry et al., 1993; Gartel and Radhakrishnan, 2005; Toledo and Wahl, 2006) . The p53 pathway has a crucial role in mediating growth arrest when cells are exposed to DNA-damaging agents (el-Deiry et al., 1994; Ogryzko et al., 1997) . The CDKN1A gene, mainly regulated at the transcriptional level, is a transcriptional target of the tumour-suppressor p53. Whereas induction of p21 by exposure to DNA-damaging agents results in G1-, G2-or S-phase arrest, repression of p21 expression has a variety of outcomes depending on the cellular context (Gartel, 2009 ). p21 suppresses oncogenesis by negatively regulating cell growth, as has been demonstrated in chronically damaged liver and renal epithelial cells (Willenbring et al., 2008) .
POK family proteins, and the molecular interactions among POK proteins, have potential roles in cancer development or cell differentiation by regulating CDKN1A gene transcription, as have been elegantly shown for MIZ1 and BCL6 in Bcl (Phan et al., 2005; Weber et al., 2008; Choi et al., 2009; Jeon et al., 2009; Koh et al., 2009) . Although the POK proteins Mycinteracting zinc-finger protein 1 (MIZ-1), ZBTB4 and BCL6 are known to interact with each other (Phan et al., 2005; Weber et al., 2008) , the partnerships and the functions of most of the POZ domain proteins are largely unknown. Accordingly, to analyse and understand the biological functions carried out by POZdomain proteins and by molecular interactions among POZ domains, we are in the process of determining virtually all of the protein interactions of every human POZ-domain protein using BiFC/FRET analysis (Kim et al., 2007) .
MIZ-1 (also called ZBTB17) interacts with c-Myc, ZBTB4, BCL-6 and Gfi-1 and recruits interacting proteins to the CDKN1A promoter (Peukert et al., 1997; Phan et al., 2005; Weber et al., 2008; Basu et al., 2009) . MIZ-1 was originally isolated from a yeast twohybrid screen by its ability to bind to c-Myc (Peukert et al., 1997) . MIZ-1 can either repress or activate the transcription of target genes depending on the interacting protein. MIZ-1 was shown to act as a potent transcriptional activator of CDKN1A. However, the oncoprotein c-Myc, by interacting with MIZ-1, represses the transcription of the genes involved in cellular differentiation and metabolism, such as the CDK inhibitor genes p15INK4B and CDKN1A (Peukert et al., 1997; Phan et al., 2005; Weber et al., 2008; Basu et al., 2009) . By interacting with MIZ-1, c-Myc is recruited to the CDKN1A promoter and directs cells to determine cell fate, either cell cycle arrest or apoptosis.
In colon cancer cells, inhibition of p21 expression by cMyc-MIZ-1 changes the p53-dependent response from cell cycle arrest to apoptosis (Seoane et al., 2002) . MIZ-1 also interacts with BCL-6, another POK protein, via their POZ-domains, and this interaction is important in the transcriptional repression of CDKN1A and in the development of Bcl (Phan et al., 2005) . Additionally, Gfi-1 and MIZ-1 form a ternary complex with c-Myc and together repress CDKN1A. c-Myc has been shown to induce lymphomagenesis. It has been suggested that the ternary complex of Gfi-1, MIZ-1 and c-Myc is important in the regulation of cell cycle and has an effect on lymphomagenesis through the transcriptional regulation of CDKN1A (Liu et al., 2010) .
Using BiFC/FRET analysis, we recently found that MIZ-1 interacts with the POK protein Kr-pok (also called ZBTB36, ZNF857C in humans) via its POZ domain. KR-POK (kidney cancer-related POZ-domain Kru¨ppel zinc-finger protein) is a proto-oncoprotein that is highly expressed in majority of malignant kidney cancer tissues, and there is a strong correlation between kidney cancer development and KR-POK expression levels. Murine KR-POK, indicated as Kr-pok, stimulates cell proliferation and represses the transcription of CDKN1A and by recruiting co-repressor-HDAC complexes, causing deacetylation of histones H3 and H4 (unpublished data). Accordingly, molecular interactions between Kr-pok and MIZ-1 can have significant effects on cell cycle regulation by MIZ-1.
MIZ-1 has an antagonistic function with Kr-pok in the transcriptional regulation of CDKN1A and other genes of the p53 pathway. In this study, we investigated whether the two proteins, MIZ-1 and Kr-pok, have important roles in regulating the transcription of CDKN1A. Our data suggest that Kr-pok competes with MIZ-1 to bind to the CDKN1A proximal regions, including MIZ-1-binding sites, and in this way interferes with transcriptional activation by MIZ-1. The binding competition between Kr-pok and MIZ-1 on the proximal promoter of the CDKN1A is functionally significant and has an important role in cell proliferation and cancer development.
Results
MIZ-1, a tumour-suppressor gene, interacts with Kr-pok To investigate that POK proteins interact with MIZ-1 and to determine the function of such protein interactions, we are in the process of investigating all of the possible protein-protein interactions among the POZdomain proteins using the pFPIA BiFC/FRET system (Kim et al., 2007) (Figure 1a) . We found that KR-POK interact with MIZ-1. Molecular interactions between the two POZ-domains of the MIZ-1 and KR-POK assembled the YFP protein, which produced yellow fluorescent light, suggesting that the two proteins interact with MIZ-1 via their POZ-domains in vivo ( Figure 1b) . As reported previously, the POZ-domains of MIZ-1 and BCL6 interacts with each other and gave a yellow fluorescent light in this assay system (Phan et al., 2005) (Supplementary Figure 1a) .
To confirm the molecular interaction between the two proteins, we carried out co-immunoprecipitation and glutathione S-transferase (GST)-fusion protein pulldown assays. Co-immunoprecipitation of the HEK293A cells transiently transfected with FLAG-Kr-pok expression vector and MIZ-1-Myc expression vector, followed by western blot analysis with anti-FLAG antibody and anti-MIZ-1 antibody, showed that Kr-pok interacts with MIZ-1 (Figure 1c) . Reverse co-immunoprecipitation of the same extract revealed that MIZ-1 interacts with Kr-pok (Supplementary Figure 1b) . Furthermore, GST-POZMiz-1 or GST-POZKr-pok fusion protein pull-down assays of [ 35 S]-methionine labelled synthetic Kr-pok or MIZ-1 protein showed that the two proteins interacts with each other probably via their POZ domains (Figure 1d ).
Kr-pok represses transcriptional activation of the CDKN1A by MIZ-1. MIZ-1 has been shown to activate the transcription of CDKN1A (Seoane et al., 2002) . We investigated the functions of Kr-pok and the protein interaction between Kr-pok and MIZ-1 on the transcription of CDKN1A. HEK293A cells were transiently co-transfected with pcDNA3.1-MIZ-1 and/ or pcDMA3.1-Kr-pok. Quantitative reverse transcriptase-PCR and western blot analysis showed that MIZ-1 and Kr-pok were overexpressed and that while MIZ-1 Figures 2a and b) . Alternatively, a loss of function approach using RNA interference directed at Kr-pok mRNA reversed the transcriptional repression by Kr-pok (Figure 2a) . Also knock-down of MIZ-1 mRNA by small interfering RNA (siRNA) against MIZ-1, decreased the transcription of CDKN1A (Figure 2b ). Additional western blot and semi-quantitative reverse transcriptase-PCR analysis of endogenous p21 expression after knock-down of MIZ-1 and/or KR-POK mRNA showed similar results with Figures 2a and b suggesting that the two proteins regulate the transcription and expression of CDKN1A gene (Figure 2c ).
Kr-pok represses the transcriptional activation of CDKN1A by MIZ-1 by acting on the proximal promoter region Previous studies have shown that MIZ-1 binds to two proximal regions, MRE-A (bp, À90 to À64) and MRE-B (bp, À27 to À17), to activate the transcription of CDKN1A (Seoane et al., 2002) . c-Myc was shown to be recruited to those sites under DNA-damaging conditions (Seoane et al., 2002) . Additionally, Phan et al. (2005) showed that BCL6 was recruited to the proximal promoter region of CDKN1A by interacting with MIZ-1. Accordingly, to dissect the molecular mechanism, we first examined which region of the CDKN1A promoter is important for transcriptional regulation by Kr-pok and MIZ-1. Kr-pok repressed the transcription of the four CDKN1A promoter constructs by >70% in HEK293A cells (Figures 3a and b) . Kr-pok could repress transcription by acting on the proximal promoter sequence (bp À133 to þ 30) (Figure 3b ). MIZ-1 activated the transcription of the four CDKN1A promoter constructs by 4.5-6-fold, and the activation was stronger on the À2.3 kb promoter construct, which contained the distal p53-binding element. The assay suggests that MIZ-1 could activate transcription by acting on the proximal promoter element (bp À133 to þ 30) and can probably further increase transcription by acting on the distal p53-binding element (Figure 3c) . Transcription of the CDKN1A gene by Kr-pok and MIZ-1 is most likely regulated by the molecular events on the proximal promoter, as it is loaded with Sp1-binding GC-boxes and two MIZ-1-binding elements (MREs) overlapping with GC-boxes.
Additionally, transient transcription analysis of the CDKN1A gene with both MIZ-1 and Kr-pok in HEK293A cells was performed. Kr-pok can repress transcriptional activation by MIZ-1 on the proximal promoter element (bp À131 to þ 30), suggesting that molecular events on the short promoter are important in the transcriptional regulation by the two regulators ( Figure 3d ). Oligonucleotide pull-down assays of Kr-pok and MIZ-1 binding on the CDKN1A proximal promoter To understand the molecular mechanisms of Kr-pok and MIZ-1 action in the transcription of CDKN1A, we investigated their DNA-binding activities at the proximal regulatory elements, such as GC-boxes and MREs, by oligonucleotide pull-down assays using synthetic polypeptides prepared by in vitro transcription and translation. As reported previously, MIZ-1 binds to MRE-A and MRE-B (Seoane et al., 2002) . Additionally, we found that MIZ-1 binds to GC-box#3 and GCbox#5/6. Based on binding intensity, the MREs and GC-box#3 might be functionally more important. Interestingly, MIZ-1 also binds to the distal p53-binding elements (p53RE#1 and #2) ( Figure 4b ).
We carried out a similar experiment with FLAG-Krpok. Kr-pok binds to the MREs, but only weakly. Kr-pok binds to all of the GC-boxes and displays a strong preference for GC-box#1 and GC-box#3. Although weak, Kr-pok also binds to the distal p53RE#1 and #2 (Figure 4c ). Purified recombinant Kr-pok zinc-finger DNA-binding domain does not binds to the beads or 3 0 UTR region of CDKN1A, indicating the specificity of Kr-pok binding to the above regulatory elements (Supplementary Figure 3) . Both MIZ-1 and Kr-pok bind to the GC-box#3 which is critical in the transcription initiation, communication with p53, and synergistic transcriptional activation by p53-Sp1 under DNA-damaging conditions (Koutsodontis et al., 2001) .
Kr-pok competes with MIZ-1 to bind to the proximal promoter GC-box, MRE-B and distal p53-binding elements of CDKN1A in vitro Transcriptional repression can be accomplished by competitive binding at the same DNA element, or inhibition of transcription factor activity by proteinprotein interaction, as is the case for c-Myc, BCL6 and Gfi-1. MIZ-1 binds to two proximal sites of the CDKN1A promoter and activates transcription (Seoane et al., 2002) . Kr-pok can repress transcription by acting on the proximal promoter region. Although we have shown that MIZ-1 and Kr-pok can bind to the proximal regulatory elements (Figure 4 ), we also investigated whether Kr-pok binds to the proximal elements directly or whether it is recruited to the CDKN1A promoter by MIZ-1. Oligonucleotide pull-down assays of whole cell lysates (prepared from the HEK293A cells transiently expressing Kr-pok and/or MIZ-1) using the representative MIZ-1 and Kr-pok-binding element ( Figure 5a , GC-box#5/6 plus MRE-B; GC-box#3) showed that Kr-pok binds to the element in the absence or pres- ence of MIZ-1, but Kr-pok binding was significantly decreased by the presence of MIZ-1. Additionally, MIZ-1 binds to the element strongly, but MIZ-1 binding was decreased by the presence of Kr-pok (Figure 5b ). We saw a similar binding competition pattern of MIZ-1 and Kr-pok with GC-box#3. As in Figure 4 , Kr-pok can bind to the proximal promoter elements independently, and Kr-pok and MIZ-1 compete with each other in Figure 4 Oligonucleotide pull-down assays. Kr-pok and MIZ-1 bind to the proximal promoter GC boxes, MREs and p53-binding elements. (a) Diagram of the endogenous CDKN1A promoter-exon 1 region. Key regulatory elements such as distal p53-binding elements (p53RE#1, #2), proximal Sp1-binding GC-boxes, and MREs are indicated. (b, c) Oligonucleotide pull-down assays of MIZ-1 binding. Streptavidin agarose beads linked to biotinylated oligonucleotides probes (GC-boxes, MREs, p53REs) were incubated with synthetic MIZ-1 or Kr-pok polypeptide prepared by in vitro transcription and translation. The precipitates were analysed by western blotting using anti-Miz-1 antibody or anti-FLAG antibody.
binding to the elements (Figure 5c ). Interestingly, ectopic MIZ-1 increases Sp1 binding, which is decreased by Kr-pok. This could explain the synergistic activation by MIZ-1 and Sp1 and the antagonistic relationship between MIZ-1 and Kr-pok (Figure 5c ). MIZ-1 and Kr-pok bind to the distal p53 elements (Figure 5d ).
Kr-pok competes with MIZ-1 to bind to the distal regulatory regions spanning p53-binding elements of CDKN1A, which increases p300 co-activator recruitment in vitro oligonucleotide pull-down assays indicated the potential binding competition between Kr-pok and MIZ-1 at the proximal and potentially also at distal regulatory regions. Using primer sets designed to amplify the two distal p53-binding elements (Figure 6a) , we analysed the binding competition between the two factors using chromatin immunoprecipitation (ChIP) assays in the HEK293A cells that were transiently co-transfected with Myc-MIZ-1 and increasing amounts of FLAG-Kr-pok expression vectors, or vice versa. The ChIP assays showed that, with increasing expression of FLAG-Kr-pok, the binding of MIZ-1 to the CDKN1A promoter was decreased (Figure 6b ). In contrast, with increasing expression of MIZ-1, the binding of FLAGKr-pok on the CDKN1A promoter was decreased Figure 5 Kr-pok competes with MIZ-1 to bind to the Sp1-GC-box#5/6-MRE, Sp1-GC-box#3, and p53RE#1 and #2 elements of CDKN1A. (a) Diagram of the endogenous CDKN1A promoter-Exon 1 region. Key regulatory elements such as distal p53-binding elements (p53RE#1 and #2), proximal Sp1-binding GC-boxes, and MREs are indicated. (b, c, d) Oligo pull-down assays. Whole cell lysates of HEK293A cells transfected with Myc-MIZ-1 and/or FLAG-Kr-pok were incubated with the oligonucleotide probes conjugated to Streptavidin agarose beads. Sp1-GC-box#5/6-MRE (bp, -56 to -17), GC-box#3 (bp, -55 to -63), p53RE#1 (bp, -2267 to -2237 ) and #2 (bp, -1384 to -1354). Proteins bound to the probes were precipitated by centrifugation and analysed by western blotting. ( Figure 6c ).The results suggest that Kr-pok competes with MIZ-1 to bind the distal regulatory region, including p53RE#1. We observed a similar binding competition between MIZ-1 and Kr-pok at the distal p53-binding element (p53RE#2) (Figures 6e and f) .
The MIZ-1-p300 complex has an important role in activating the transcription of MIZ-1 target genes, such as p15INK4b and CDKN1A, through MIZ-1-mediated recruitment of the co-activator p300 (Piluso et al., 2002) . As Kr-pok can repress transcription activation by MIZ-1, we investigated whether Kr-pok could inhibit transcription by decreasing p300 recruitment to the CDKN1A promoter. ChIP assay was performed using HEK293A cells that were co-transfected with a combination of pcDNA3.1-MIZ-1 and an increasing amount of FLAG-Kr-pok or pcDNA3.1-Kr-pok and an increasing amount of MIZ-1 expression vector. Although MIZ-1 increases p300 binding in a dosedependent manner, increased Kr-pok binding to the CDKN1A promoter decreased p300 binding (Figures 6d  and g ). This indicates that Kr-pok could displace both MIZ-1 and p300 at the CDKN1A promoter by competing with MIZ-1 for promotor-binding sites.
As Kr-pok and MIZ-1 can bind to the distal p53RE#1 and #2, we tested whether Kr-pok and MIZ-1 affect p53 binding by ChIP assays. MIZ-1 alone increases binding of endogenous p53 to the region, while Kr-pok decreases p53 binding enhanced by MIZ-1 (Figure 6h ). Accordingly, we investigated whether Kr-pok, p53, and MIZ-1 can affect the transcription of CDKN1A promoter constructs including p53-binding sites (Supplementary Figure 4a ). MIZ-1 and p53 activate transcription independently and the two transcription factors activate transcription of CDKN1A promoter synergistically. In contrast, Kr-pok represses transcriptional activation by either MIZ-1 or p53 (Supplementary Figure 4b ). Co-immunoprecipitation shows that MIZ-1 and p53 interact with each other and synergistic transcription activation by the two proteins may be possible by the interaction (Supplementary Figure 4c) .
Kr-pok competes with MIZ-1 to bind to the proximal promoter region of the CDKN1A, which decreases p300 co-activator recruitment and histone acetylation In vitro oligonucleotide-binding assays indicated binding competition between Kr-pok and MIZ-1 at the key regulatory elements of the CDKN1A proximal promoter. Using ChIP assays, we tried to demonstrate the binding competition between Kr-pok and MIZ-1in the HEK293A cells that were transiently co-transfected with Myc-MIZ-1 and increasing amounts of FLAG-Kr-pok, or vice versa using the primers as indicated in Figure 7a . At the proximal promoter, with increasing expression of FLAG-Kr-pok, MIZ-1 binding was decreased. In contrast, with increasing expression of MIZ-1, the binding of FLAG-Kr-pok was decreased (Figures 7b  and c) .
The transcriptional co-activator p300 is targeted to regulatory elements or promoters by interactions with transcription factors, and acetylates nearby histones to open up nucleosome structure to activate transcription (Ogryzko et al., 1996) . As is the case with the distal promoter elements containing p53RE#1 and RE#2, there is a binding competition between Kr-pok and MIZ-1 at the proximal promoter. As Kr-pok binding to the proximal promoter increases, p300 binding is decreased because of the displacement of the MIZ-1-p300 complex (Figure 7d ). ChIP assays of the HEK293A cells transiently transfected with pcDNA3.1-MIZ-1 and/or FLAG-Kr-pok showed that, at the proximal promoter, while MIZ-1 increased acetylation of histone H3 and H4, Kr-pok decreased the acetylation status. When Kr-pok and MIZ-1 were co-expressed, the increased histone acetylation of histones H3 and H4 by the MIZ-1/p300 complex was decreased by Kr-pok (Figure 7e ).
The oligonucleotide pull-down or ChIP assays suggested Kr-pok compete with MIZ-1 and may also with Sp1 (Figures 4b and c; Figures 5b and c) . Accordingly, we investigated whether Kr-pok can affect the transcription of minimal promoter constructs with the Sp1 binding GC-box. Interestingly, while MIZ-1 and Sp1 can independently or synergistically activate the transcription of pG5-5x(GC)-Luc, Kr-pok represses transcriptional activation by Sp1 (Supplementary Figure 5) .
Kr-pok reverses MIZ-1 activity on cell cycle regulation As Kr-pok could repress the transcriptional activation of CDKN1A by competing with MIZ-1, we examined whether Kr-pok represses MIZ-1-mediated cell cycle regulation using fluorescence-activated cell sorting analysis of HEK293A cells transfected with MIZ-1 and/or KR-POK siRNA. Knockdown of MIZ-1 increased the S-phase cell population from 13.6 to 18.2%. Knockdown of KR-POK decreased the S-phase cell population from 13.6 to 7.9%. Knockdown of both KR-POK and MIZ-1 resulted in a cell population in which 12.1% of the cells were in S phase (Figure 8a ). Additionally, we used 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assays to examine whether Kr-pok can promote cell proliferation. Although MIZ-1 decreased the cell proliferation rate, Kr-pok stimulated cell proliferation. The MIZ-1 inhibition of cell proliferation was decreased when Kr-pok was coexpressed ( Figure 8b ). We also examined whether the cell growth arrest induced by MIZ-1 can be reversed by Kr-pok in HeLa cells with a foci-formation assay. HeLa cells were transfected with MIZ-1 and/or Kr-pok expression vectors and allowed to grow in the presence of G418. Although MIZ-1 decreased the number of HeLa cell foci by growth arrest and/or apoptosis, ectopic Kr-pok expression increased number of large transformed foci, suggesting that Kr-pok caused cellular transformation into fast growing cells. The HeLa cells co-transfected with both MIZ-1 and Kr-pok expression vectors showed more transformed colonies than the HeLa cells transfected with only the MIZ-1 expression vector. These data suggest that the growth arrest and/or apoptosis effect of MIZ-1 is significantly reversed by Kr-pok ( Figure 8c ).
As MIZ-1 induces growth arrest as reported and activates transcription of other genes of the p53 pathway such as TP53 and ARF (unpublished data), we investigated whether MIZ-1 showed apoptotic activity and also whether the apoptosis induced by MIZ-1 can be reversed by Kr-pok, by fluorescence-activated cell sorting analysis using Annexin-V staining. MIZ-1 increased the apoptotic cell population significantly (from 1.7 to 14.8%), and the apoptotic cell population was significantly decreased by co-expression of Kr-pok (from 14.8 to 3.1%) (Figure 8d ). These data suggest that functions of MIZ-1 on cell cycle regulation could be suppressed by Kr-pok.
KR-POK expression increases in human tumours
In 68% of malignant kidney cancer tissues, KR-POK expression is significantly higher than in normal tissues (data not published). In addition, data obtained from a publicly available database of tumour expression profiles show that KR-POK expression is relatively high in other cancer types (1.5B3.6-fold in glioblastoma; 2.2-fold in smouldering myeloma) compared with control tissues, while the expression level of MIZ-1 is either decreased or remains unchanged (0BÀ1.8-fold in glioblastoma; no change in smouldering myeloma) relative to control tissues (www.oncomine.org) (Figures  9a-c) . Our biochemical data on KR-POK and the high correlation between KR-POK expression level and tumourigenesis suggest that KR-POK is a protooncogene. The changes in expression in tumour tissues suggest that abundant KR-POK binds to the CDKN1A promoter more effectively than MIZ-1 and so represses transcription and stimulates cell proliferation. Interestingly, when immortalised normal HEK293A cells are challenged with etoposide, the expression of MIZ-1 mRNA is increased and that of KR-POK is decreased as part of the cellular defence mechanism against genotoxic stress (Figure 9d ). It appears that in cancer cells, this cellular defence mechanism is disrupted; the KR-POK level is high, while the MIZ-1 level is relatively low.
Discussion
Kr-pok is a member of the POK family of transcription factors. Kr-pok is overexpressed in kidney cancer tissues and is a potential proto-oncoprotein that stimulates cell proliferation (in preparation). Kr-pok is a potent regulator of gene expression of the p53 pathway (in preparation). However, how Kr-pok represses the transcription of CDKN1A and stimulates cell proliferation was previously unknown.
MIZ-1 is known as an activator of CDKN1A gene by acting on the proximal promoter. DNase I footprinting showed that MIZ-1 binds the two regulatory elements (MRE-A, bp À90 to À64 and MRE-B, bp À27 to À17) of the CDKN1A proximal promoter that overlap with the Sp1-binding GC-boxes (#2 and #5/6) (Seoane et al., 2002) . Interestingly, our oligonucleotide pull-down assays showed that MIZ-1 binds to additional regulatory elements, such as distal p53RE#1, p53RE#2, GC-box#3, GC-box#4 and GC-box#5/6. In terms of binding affinity, MRE-A (partially overlapping with GC-box#2), MRE-B (overlapping with GC-box#5/6) and GC-box#3 may be more important in the transcriptional regulation of CDKN1A gene by MIZ-1. Accordingly, any regulatory molecules interacting with MIZ-1 or binding these elements can potentially affect the transcriptional activity of MIZ-1 (Figure 10b) .
We demonstrate that Kr-pok can repress transcription on the reporter construct with short promoter elements (bp, À133 to þ 30) containing two proximal MREs and Sp1-binding GC-box elements. Interestingly, unlike other ZBTB proteins investigated so far (ZBTB2, 5, ZBTB7A, and so on), Kr-pok can bind to all of the GC-box elements and MREs, although it shows Figure 9 KR-POK expression is increased in human tumours. (a-c) KR-POK expression is increased in glioblastoma (1.5B3.6 Â ) and smouldering myeloma (2.2 Â ) compared with control tissue, while MIZ-1 expression is either decreased or remains unchanged in glioblastoma (0BÀ1.8 Â ) and smouldering myeloma (no change) relative to control tissue. The data are obtained from www.oncomine.org (Zhan et al., 2007; Lee et al., 2006; Sun et al., 2006) . Data presented as a Box and Whisker graph with error bars representing the 10th and 90th percentiles. a relatively higher affinity for GC-box#1 and #3 (Figure 10c ). This suggests that Kr-pok binding to GCbox#1 and #3 is likely more important in transcriptional repression. Both MIZ-1 and Kr-pok bind to GC-box#3, which is critical not only in basal transcription but also in communication and synergistic transcriptional activation between Sp1 bound at the proximal GC-box#3 and p53 bound on the distal elements for inducible expression of p21 (Koutsodontis et al., 2001) .
As MIZ-1 and Kr-pok interact with each other, we initially considered a repression mechanism similar to the molecular mechanisms proposed for lymphomagenesis by MIZ-1-mediated recruitment of BCL6, c-Myc and Gfi-1 (Phan et al., 2005; Basu et al., 2009; Liu et al., 2010) . However, the ChIP assays and binding analysis of the CDKN1A promoter suggested that MIZ-1 and Kr-pok compete with each other in the transcriptional regulation and that binding site competition may be a molecular mechanism that regulates cell proliferation in normal and tumour tissues (Figure 9) .
We found that Kr-pok can repress MIZ-1-dependent transcriptional activation of the cell cycle arrest gene CDKN1A in HEK293A cells and that, in doing so, it stimulates cell proliferation. Mechanistically, Kr-pok binds to the proximal GC-boxes, particularly GC-box#1 and #3, and also to the MIZ-1-binding sites (MRE-A and -B). MIZ-1 binds to MRE-A, MRE-B and also GC-box#3. Kr-pok represses the transcription of the CDKN1A by competing with MIZ-1, displacing the MIZ-1-p300 complex, and deacetylating histones at the proximal promoter. Our data showed how MIZ-1 and Kr-pok, as well as the molecular interplay between the two factors, could regulate cell proliferation by modulating CDKN1A gene transcription (Figure 10) . Figure 10 Hypothetical model of transcriptional regulation of CDNK1A by p53, MIZ-1 and KR-POK. (a) p53, Sp1 and co-activator in transcriptional activation of the CDKN1A. p53 is induced by genotoxic stress, binds to the distal p53-binding elements and communicates with Sp1 to activate transcription synergistically. Sp1 is responsible for basal transcription. GC-box#3 is critical in both basal transcription and synergistic transcription activation by Sp1-p53 interaction. Solid line with arrowhead (-), transcriptional activation; solid line with double arrowhead (2), protein interaction. (b) Transcriptional activation by MIZ-1 and co-activator. MIZ-1 activates transcription by binding to the proximal elements such as MRE-A, GC-box#3, and GC-box#5/6, and MRE-B. Although mechanistically not shown, MIZ-1 synergistically activates transcription by interacting with Sp1 in the region. (c) Transcriptional repression by Kr-pok and co-repressor in the proximal promoter region. Kr-pok binds primarily to GC-box#1 and #3 and also weakly to other GC boxes and MREs. Kr-pok appears to compete with either MIZ-1 or Sp1 to repress transcription, particularly binding competition at GC-box#3 may be important. (d) Molecular mechanism of transcriptional regulation of CDKN1A by MIZ-1 and Kr-pok. Transcriptional activation by MIZ-1 can be repressed by Kr-pok at the proximal promoter, via binding competition at GC-box#3 and MREs. MIZ-1 can bind to distal p53-binding elements, which can also be competed by Kr-pok. MIZ-1 interacts with p53 and increases p53 binding. The two proteins synergistically activate transcription. KR-POK displaces the MIZ-1/ p300 complex and recruits the co-repressor HDAC complex, which deacetylates histones Ac-H3 and Ac-H4 at the proximal promoter to repress transcription. Thickness of arrows, DNA-binding intensity; MRE, MIZ-1-binding elements; p53RE, p53-binding element; Tsp ( þ 1), transcription start point; ZF, zinc-finger DNA-binding domain; x, transcription repression.
Interestingly, we found that MIZ-1 binds to the distal p53-binding elements. It also interacts with p53 and increases p53 binding in the region, MIZ-1 and p53 synergistically activate transcription of CDKN1A in HCT116 p53-null cells. MIZ-1 can activate transcription alone and it also synergistically activates transcription with Sp1. Molecular events among Kr-pok, p53, Sp1 and MIZ-1 in the regulation of CDKN1A transcription can be intriguing. When cells are under genotoxic stress condition, expression of MIZ-1 and p53 is greatly induced and molecular interactions among p53, MIZ-1 and Kr-pok at the distal p53RE may regulate CDKN1A gene transcription. In low p53 expression condition, interactions among Kr-pok, Sp1 and MIZ-1 at the proximal promoter are likely a major determinant of p21 expression.
Kr-pok uses a unique strategy to block the transcription of the negative cell cycle regulatory gene CDKN1A by blocking the transcriptional induction by p53, MIZ-1 and Sp1 and, more specifically, by binding the key regulatory elements GC-box#3 and two flanking GC boxes #1 and #5/6 that otherwise are bound by MIZ-1 and Sp1. The mechanism we proposed here is different from the models proposed for MIZ-1/BCL6, MIZ-1/Gfi-1 and Myc/MIZ-1 for lymphomagenesis (Phan et al., 2005; Basu et al., 2009; Liu et al., 2010) . MIZ-1 was shown to interact with the transcriptional co-activator p300 with HAT activity to activate transcription by acetylating histones H3 and H4 at the proximal promoter (Piluso et al., 2002) . The binding of Kr-pok displaces the MIZ-1-p300 complex from the promoter, resulting in deacetylated histones and transcriptional repression (Figure 10d) .
Overall, our studies suggest that Kr-pok is a transcriptional repressor with oncogenic potential and that, when overexpressed, Kr-pok stimulates cell proliferation. As MIZ-1 and Kr-pok MIZ-1 and Kr-pok are involved in cell cycle regulation, the cellular context of MIZ-1 and Kr-pok in normal or cancer cells can be important in the regulation of cell proliferation.
Materials and methods
Plasmids, antibodies and reagents CDKN1A-Luc plasmid was kindly provided by Dr Yoshihiro Sowa of the Kyoto Perpetual University of Medicine (Kyoto, Japan). The pcDNA3-FLAG-Kr-pok, pcDNA3.1-Kr-pok, and pcDNA3.1-MIZ-1 plasmids were prepared by cloning complementary DNA fragments into pcDNA (Invitrogen, Carlsbad, CA, USA). CDKN1A-Luc -1462 bp, CDKN1A-Luc À864 bp and CDKN1A-Luc À133 bp CDKN1A promoter and luciferase gene fusion reporter plasmids were cloned from the CDKN1A-Luc plasmid. All plasmid constructs were verified by DNA sequencing. Antibodies against p21, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), FLAG tag, Ac-H3, and Ac-H4 were purchased from Upstate (Charlottesville, VA, USA), Chemicon (Temecula, CA, USA), Calbiochem (San Diego, CA, USA) and Santa Cruz Biotechnology (Santa Cruz, CA, USA). Most of the chemical reagents were purchased from Sigma (St Louis, MO, USA).
Cell cultures HEK293A, HCT116 p53 null and HeLa cells were cultured in Dulbecco's modified Eagle medium (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen).
Transcriptional analysis of CDKN1A promoter pGL2-CDKN1A-Luc promoter reporter fusion plasmids as well as pcDNA3-FLAG-Kr-pok, pcDNA3.1-MIZ-1 and pCMV-LacZ in various combinations were transiently transfected into HEK293A cells using Lipofectamine Plus reagent (Invitrogen). After 36-48 h of incubation, cells were harvested and analysed for luciferase activity. Reporter activity was normalised with co-transfected b-galactosidase activity or protein concentration for transfection efficiency.
To analyse the effect of the Kr-pok and MIZ-1 on the transcriptional activation of CDKN1A by p53, pGL2-CDKN1A-Luc (À2.3 kb) as well as pcDNA3-FLAG-Kr-pok, pcDNA3.1-MIZ-1, pcDNA-p53 and pCMV-LacZ in various combinations were transiently transfected into HCT116 p53 null cells using Lipofectamine Plus reagent (Invitrogen). After 36-48 h of incubation, cells were harvested and analysed as above.
Purification of GST fusion proteins and GST fusion protein pull-down assays pcDNA3.1-MIZ-1 and pcDNA3.0-FLAG Kr-pok expression plasmids were prepared as described in the plasmid section of material and methods. The plasmids were transformed into Escherichia coli BL21 (DE3). Recombinant GST-fusion proteins were prepared as reported elsewhere . Agarose-bound GST or GST fusion protein was washed five times with cold HEMG (40 mM HEPES, pH 7.9, 0.2 mM EDTA, 5 mM MgCl 2 , 1.5 mM dithiothreitol, 10% glycerol, 100 mM KCl, protease inhibitor 1 tablet/50 ml (Roche, Mannheim, Germany)) buffer and collected by centrifugation at 3000 r.p.m at 4 1C for 1 min. Agarose-bound GST protein was incubated with ]-methionine-labelled synthetic Kr-pok and MIZ-1 proteins were prepared using the TNT Quick-coupled Transcription/Translation System (Promega, Madison, WI, USA). After the agaroseprotein complex was washed five times with 1 ml of cold HEMG buffer, the bound proteins were resolved by 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The gels were dried (Hoefer Scientific Instruments, San Francisco, CA, USA) and exposed to X-ray film on an image-intensifying screen (Kodak, Rochester, NY, USA).
RNA isolation and quantitative real-time PCR and semi-quantitative PCR Total RNA was isolated from the HEK293A cells using TRIzol reagent (Invitrogen). Complementary DNAs were synthesised using 5 mg of total RNA, oligo-dT (10 pmol), and Reverse transcriptase II (200 units) in 20 ml using a reverse transcription kit (Promega). Quantitative reverse transcriptase-PCR was performed using SYBR Green Master Mix (Applied Biosystems, Carlsbad, CA, USA Co-immunoprecipitation assays HEK293A cells were washed, pelleted and resuspended in a lysis buffer supplemented with protease inhibitors (20 mM Tris-HCl, pH7.5, 150 mM NaCl, 10% glycerol, 1% Triton X-100). Cell lysate was precleared, and the supernatant was incubated overnight with anti-MIZ-1 or anti-FLAG on a rotating platform at 4 1C, followed by incubation with protein A-sepharose fast flow beads. Beads were collected, washed and resuspended in equal volumes of 5 Â sodium dodecyl sulfate loading buffer. Immunoprecipitated proteins were separated with 12 % sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The western blot assay was performed as described above using appropriate antibodies.
Oligonucleotide pull-down assays HEK293A cells were lysed in HKMG buffer (10 mM HEPES pH 7.9, 100 mM KCl, 5 mM MgCl 2 , 10% glycerol, 1 mM DTT and 0.5% NP-40). Cellular extracts were incubated with 1 mg of biotinylated double-stranded oligonucleotides for 16 h. The sequences of the oligonucleotides are listed as follows (only nucleotide sequences of sense strands are shown): p53RE#1, 5 0 -GTCAGGAACATGTCCCAACATGTTGAGC TC-3 0 ; p53RE#2, 5 0 -TAGAGGAAGAAGACTGGGCATGT CTGGGCA-3 0 ; GC-box#1, 5 0 -GATCGGGAGGGCGGTC CCG-3 0 ; GC-box#2, 5 0 -GATCTCCCGGGCGGCGCG-3 0 ; GC-box#3, 5 0 -GATCCGAGCGCGGGTCCCGCCTC-3 0 ; GC-box#4, 5 0 -GATCCTTGAGGCGGGCCCG-3 0 ; GC-box#5/6, 5 0 -CCTTGAGGCGGGCCCGGGCGGGGCGGTTGTATA TC-3 0 ; Miz-1RE-A, 5 0 -GGGCGGCGCGGTGGGCCGAG CGCGGG-3 0 ; Miz-1RE-B, 5 0 -TATATCAGGGCCGC-3 0 . To collect DNA-bound proteins, the mixtures were incubated with Streptavidin-agarose beads for 2 h, washed with HKMG buffer and precipitated by centrifugation. The precipitate was analysed by western blot assay as described above.
Additionally, we tested whether purified recombinant GST and GST-Kr-pok zinc-finger DNA-binding domain protein can bind to the probes directly. The proteins were incubated with 1 mg of biotinylated double-stranded oligonucleotides for 16 h. The sequences of the oligonucleotides are listed as follows (only nucleotide sequences of sense strands are shown): GCboxes (which described above); 3 0 -UTR, 5 0 -CTCACCTCCTC TAAGGTTGGGCAGGGTGAC-3 0 ; To collect DNA-bound proteins, the mixtures were incubated with Streptavidinagarose beads for 2 h, washed with HKMG buffer and precipitated by centrifugation. The precipitate was analysed by western blot assay as described above.
Annexin-V staining
The Annexin-V-FITC Apoptosis Detection Kit (BD Biosciences) was used to detect apoptosis by flow cytometry. HEK293A cells were transfected with the pcDNA3.1-MIZ-1 and/or pcDNA3.0-FLAG-Kr-pok expression vectors. All cells were harvested (including detached cells) and processed according to the manufacturer's instructions. Cells were washed and resuspended with 1 Â binding buffer at a concentration of 1 Â 10 6 cells/ml, and 100 ml of the solution (1 Â 10 5 cells) was transferred to a 5 ml culture tube. In all, 5 ml of Annexin-V-fluorescein isothiocyanate and 5 ml of propidium iodide were added to the solution, followed by gentle vortexing of the cells and incubation for 15 min at room temperature in the dark. In total, 400 ml of 1 Â binding buffer was added to each tube. Apoptosis of cells was analysed by FACS Calibur (BD Biosciences) within 1 h. Data were analysed using BD CellQuest Prosoftware (BD Biosciences, San Jose, CA, USA).
Colony foci formation assay HeLa cells (1 Â 10 5 cells per well) were transfected with pcDNA3 or pcDNA3-FLAG-Kr-pok (0.5 mg/ml) and/or pcDNA3.1-MIZ-1 (0.5 mg/ml). Transfected cells were cultured for 2 weeks in the presence of G418 (800 mg/ml), and colonies resistant to G418 were stained with crystal violet (0.5% in 20% ethanol).
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assays Confluent HEK293A cells grown on 10-cm culture dishes were transfected with the pcDNA3.1-MIZ-1 and pcDNA3.0-FLAG-Kr-pok expression vectors, and the cells (1.5 Â 10 5 ) were transferred to six-well culture dishes and grown for 0-6 days. At 0, 2, 4 and 6 days, the cells were incubated for 1 h at 37 1C with 20 ml per well 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (2 mg/ml). Precipitates were dissolved with 1 ml of dimethylsulfoxide. Cell proliferation was determined from the conversion of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide to formazan using a SpectraMAX 250 (Molecular Device Co., CA, USA) at 570 nm.
Statistical analysis
A w 2 test or Fisher's exact test were used for statistical analyses as appropriates. All statistical tests were two-sided and P-values of o0.05 were considered statistically significant.
